Distinct Clinical and Pathological Features Are Associated with the BRAFT1799A(V600E) Mutation in Primary Melanoma
- 1 April 2007
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 127 (4), 900-905
- https://doi.org/10.1038/sj.jid.5700632
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Epidemiology of solar keratosesBritish Journal of Dermatology, 2006
- Distinct Sets of Genetic Alterations in MelanomaNew England Journal of Medicine, 2005
- BRAFE600-associated senescence-like cell cycle arrest of human naeviNature, 2005
- Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progressionNature, 2005
- Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interferenceOncogene, 2004
- B-RAF is a therapeutic target in melanomaOncogene, 2004
- The Influence of Painful Sunburns and Lifetime Sun Exposure on the Risk of Actinic Keratoses, Seborrheic Warts, Melanocytic Nevi, Atypical Nevi, and Skin CancerJournal of Investigative Dermatology, 2003
- The melanocortin-1-receptor gene is the major freckle geneHuman Molecular Genetics, 2001
- Mitogen-activated protein kinase pathwaysCurrent Opinion in Cell Biology, 1997
- Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) geneNature Genetics, 1994